Summit Global Investments Biogen Inc. Transaction History

Summit Global Investments

$1.57 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$190.52 - $236.72 $183,280 - $227,724	962 New	962 $223,000
Q4 2023 Feb 06, 2024	BUY	$222.59 - $267.94 $1.36 Million - $1.63 Million	6,088 New	6,088 $1.58 Million
Q2 2021 Jan 28, 2022	SELL	$259.0 - $414.71 $1.54 Million - $2.47 Million	-5,950 Closed	0 $0
Q1 2021 Jan 27, 2022	BUY	$242.95 - $284.63 $1.45 Million - $1.69 Million	5,950 New	5,950 $1.67 Million
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $1.65 Million - $2.49 Million	-7,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $1.55 Million - $1.79 Million	5,849 Added 508.17%	7,000 $1.99 Million
Q2 2020 Aug 11, 2020	BUY	$258.66 - $342.55 $76,046 - $100,709	294 Added 34.31%	1,151 $308,000
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $15,593 - $19,780	-58 Reduced 6.34%	857 $271,000
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $201,354 - $278,224	915 New	915 $272,000
Q3 2019 Nov 08, 2019	SELL	$217.44 - $243.88 $195,043 - $218,760	-897 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$219.29 - $241.72 $11,403 - $12,569	-52 Reduced 5.48%	897 $210,000
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $3,467 - $5,423	16 Added 1.71%	949 $224,000
Q4 2018 Feb 08, 2019	SELL	$278.5 - $352.75 $1.4 Million - $1.78 Million	-5,039 Reduced 84.38%	933 $281,000
Q3 2018 Nov 15, 2018	SELL	$293.51 - $383.83 $32,286 - $42,221	-110 Reduced 1.81%	5,972 $2.11 Million
Q2 2018 Aug 10, 2018	SELL	$257.52 - $306.91 $4.7 Million - $5.6 Million	-18,248 Reduced 75.0%	6,082 $1.77 Million
Q1 2018 May 03, 2018	SELL	$260.13 - $367.91 $1.47 Million - $2.08 Million	-5,663 Reduced 18.88%	24,330 $6.66 Million
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $9.23 Million - $10.3 Million	29,993	29,993 $9.56 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.

Account